for you everyone and Good Carolyn. joining thank today. our Thanks afternoon call
line revenue, revenue quarter metrics outperformed adjusted strong service services Excellent professional EBITDA. exceeding the key and proud revenue, across results professional I first board team top all excellent and to performance. our utilization strong guidance combined and disciplined very drove quarter renewals performances. am bottom very execution, Our subscription start expense management including total line of we the the resulted sales year. This the with posted in
look on driving XX% we profitable and remain As exit out targeting call, last are cloud our highlight. growth fiscal a that accelerates. as XXXX our QX we like focused on Two important me metrics discussed rate, as we growth at business year stand ahead, the to to ARR I'd to
First, ARR and by our QX best in gross year-over-year, history. Company's was bookings grew XX% quarter SaaS the the
As this this encouraging over to business. we've see quarters, the we booked and to pipeline noted is strong have past a few convert
growth levers move strong a great A the cloud, year logo our of are customers, feel well we've and short, international pipelines. the had closed transitions. our start SaaS levers we finally in In new on to All contributed up-sell and cross-selling as ahead. to SaaS expansion. existing To recap, we we months, quarter strategic that occur our four about good acquisition to our as transitions customers growth as premise our continued growth few
premise momentum of our simplify year, SaaS cloud substantial our impact customers SaaS growth to leverage in has more which cloud. The of phase on our as of discussed remaining we start and As on call, demonstrates to enables on year business. a projects allows the our to and cross positive long-term, is model important for customers the getting as part to last of a business the ARR pivotal the us to a this expect continued us a over because out sell acts catalyst this operations, we And get be up-sell. our transitions move our it all to investments. final and QX
strategy recast as Given declined our levels. seeing our is how view positive the we working. an success cloud cloud a company to we point to compared that are maintenance at evidence see with is net N are, illustrate a a recent company, We rate. to we're making and rate this is accelerating retention One the progress as dollar to SaaS Model as strategic also transitions, continue it final our as our products
For ending dollar gross as that of valuable our used Alongside retention strong on building business. target excess SaaS retention metrics a rate durable our XXX% our rate, XXXX, we've points period the are net December XXX%. these and of we XX-month was XX, in proof
we to was some deals Sciences transitions, from a mix closed Tech like signed over business And last renewals. both expansions, Next, levers. new all healthy SaaS quarter, share similar also strong of highlights. and healthy performance from we contribution verticals. QX's by for driven High base numerous to our a and quarterly growth We I'd Life enjoyed customer logos
SaaS AstraZeneca, to Diagnostics including large ConMed. multiple the Abbott Turning and signed transitions, we customers Stryker, quarter during
customers AstraZeneca cloud. the key our of testing automated transition terrific to A moving study is our case factor a AstraZeneca value starting SaaS capabilities. is of are why our their to
of an environment. updates them compliant more innovation, regulated pharma system to advantage designed specifically stay test stay have companies, ever-changing current, in take in environment. easily This in and allows a We regulatory turn and
our Model also divisions. digital out to single Model will for support logo company serve be other XX to Turning for eventually scalable Japan. the initiative we biotech that a Stryker in to day and and growth. into version customer blueprint cloud and can this new Stryker. designed we Price growth the expect global N, markets. and the as will will in Life implementation through future. team relationship their that our future. Global will and Also, build I expand This global to that of Stryker Sciences, is will Management a quarter, instances to future in for top into customer value legacy consolidate they a demonstrate foundation is two purchased their signed operations pharma able acquisition headquartered to ways a This pricing experiencing look growth roll their one a during the consolidating quickly practices N this strong transformation across strategic
High Tech. to Turning
and in sector our this to fact Tech this of see talent year, improved are We continued based seeing up that belief High this and would We the business. in last our fruits traction team in a in investment. the part selectively on added trends pick of XXXX, we to pipeline
selected our the ability of demand buy as timelines, the a global of ground of a well deal our to channel if aggressive During platform, they companies an pricing global experience and review management, their as Model rigorous the the quarter, of Company highly the investments products Technology, our Solidigm flash working vendors market In foundational N's N. management technology recently exciting analysis management, Intel. leading that was new based signed market solution. competitive entity. conducted hit designed This a to they for sales implementation with the provider up, breadth a our was end, see It's global select and drive Model tech on determine, should spun team from as as to being company rebate out
to expand land continue strategy see dividends. pay and sales our also We
on Channel is AMD, During Marvell Diodes, Management customers N's a among critical the we and numerous systems. and AMD relies customer and had deals others. applications Western Cloud great Model Revenue quarter, expansion with including for Data Digital mission key
Our and solutions have organic years. AMD's supported in recent growth inorganic
newly N. Xilinx As move to business onto we have Model the result, a acquired earned their trust
relationship we in portfolio, their their into Xilinx well-positioned continue believe, fold future. they the to support to As expand we and our are growth
Turning professional services. to
had Europe. go-lives, year. projects team Novartis In great Our several at had Teva start including Pharmaceuticals, we Jazz to and Pfizer, another the QX, successful
welcome they may customer went management a as in in Pharmaceuticals Jazz recall, live with and we our new solution. global you As QX price QX
year Pharma to delivering Jazz focused merged person for a changing some form company GW life For on with diseases. X,XXX-plus backgrounds, serious this therapies earlier
worked templatized that time users project. we've benefit our to the successfully rapidly dozens successfully unique team go-live duration took practices express testament IT Europe engagement delivery deliver rapid team last and methodology of a couple best methodology over to quickly an just with This the of N to and approach of Our years. inception to is to this as XX to weeks value the their refined express our project Model in implementation The leveraged customers and implementation approach The from implementing our we've from that collected U.S. go-live projects. a in completed that allows approaches from and and excellence.
backlog. us world. enables on-budget business addressable This anniversary to services of in business Life services business pre-commercial the as the a differentiated continues of on-time, margin. the services the has and offering built the to strength acquisition of to deliver QX a up expect team I total to and marks Deloitte. and at Our software portfolio team continue expands XXXX, to one-year companies Sciences our substantial market, sell our in the clients largest from services best-in-class
with continue relationship our companies Germany. Business pharmaceutical and since plans. customer, QX We enjoyed Business in partnership an world's have growth based to validated this a The their with the which we at an thesis one long-term the has existing M&A customer, Services this of Services expansion performance, see solid included largest to a expand acquisition continued of support team in
Business processing. customer, and the existing into Services This an N Model Services customers. our also cross-sell software with We Business relationship Akorn expanded existing to Model Medicaid includes shows N potential now
and solution Akorn For would an that help needed Medicaid them practices. a industry partner efficiently could provide integrated services processing, best that technology leverage
on year internal sets one. on Services customers' of flexibility us meet two the to addition N of plan integrated addition our this hit profitability, truly to bullish As the This to the the plan, marketplace. the to Business sales importantly future. gives our improved needs tailor of reflect the most I overall in ahead one full Business ultimate a the business offerings today anniversary Services and We continue in portfolio. into quarters I be our year acquisition, of apart and Model The solution
customers value new longstanding and last Model product, call, innovation, to proactively our and N State Management. relationships Price Transparency to customers. more our innovate expertise introduced our to our Turning On domain allows a deep I with deliver
states longtime as These a product manufacturers drug product pricing help and requirements change. it's a one or across the of last service the on few unique as can built report drug our first our more Transparency platform announced and new general and address be of counties. flexibility drug the new built manage a is new enacted change to N's This software availability XX as we sneak new justification the it's the will we Just they customers. laws this with products any choice, because or co-developed evolving to our natively price This require provides advisor. offering. as of support laws Service. efficiently state information customers regulatory launches years about Model for over well how continuous the to State trusted with a Business that Management Its our as state as rapidly Pfizer, Price set cloud role consumed customers
team QX, am would growth strategic in that our like conclude are that by we objectives N extremely this me and our QX that with the to meet the and to continues to reiterating last to optimism and year. Let the their and of also track for laser we now in will I over year execution a I'd an turn I our and John efforts great team our discuss to like foundation and results guidance. our provide John? feel on drive years. pleased I me I'm proud financial the ahead. solid this on We've and in to growth call beyond. over that levers, gives at XXXX our I execute to update profitable believe Model several QX how on are for thank continue built focused we have